Athersys stem cells still show potential – Crain’s Cleveland Business
|
Athersys stem cells still show potential
Crain’s Cleveland Business There, regulators have eased restrictions on stem cell therapies that have proven to be safe, and MultiStem hasn't shown any safety issues. Plus, Athersys already has an ally in Japan who could help fund such a study: It struck a licensing agreement … |
